dCTPase-IN-1
dCTPase-IN-1 is a highly selective deoxycytidine triphosphate pyrophosphatase 1 (dCTPase) inhibitor with an IC50 of 20 nM. dCTPase-IN-1 functionally inhibits dCTPase, exhibits a synergistic effect in enhancing cytotoxicity, and has no inherent cytotoxicity. dCTPase-IN-1 can be used for the research of leukemia.
For research use only. We do not sell to patients.
- CAS No.: 353287-72-6
- Formula: C15H12N4O2S2
- Molecular Weight:344.41
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
All DNA/RNA Synthesis Isoforms
More
Biological Activity
dCTPase-IN-1 (compound 18) (1.0-5.0 μM; 72 h) acts synergistically with 5-Azacytidine (HY-10586) to reduce the viability of human leukemia HL60 cells[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:HL60 human leukemia cells
-
Concentration:1.0, 2.5, 5.0 μM (in combination with 2.5 μM 5-Azacytidine)
-
Incubation Time:72 h
-
Result:Synergistically increased the cytotoxicity of 5-Azacytidine, reducing HL60 cell viability without exhibiting cytotoxicity when used alone.
Chemical Information
-
CAS No. 353287-72-6
-
Molecular Weight 344.41
-
Formula C15H12N4O2S2
-
SMILES
N=1N=C(C=2SC=CC2)N3N=C(SC13)C=4C=CC(OC)=C(OC)C4
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)